- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.
Andere Kunden interessierten sich auch für
- Drug Resistance in Cancer Cells182,99 €
- Neville WillmottMicrospheres and Regional Cancer Therapy494,99 €
- Robert F. Ozols (ed.)Molecular and Clinical Advances in Anticancer Drug Resistance238,99 €
- William N. Hait (ed.)Drug Resistance358,99 €
- B.A. Ponder (ed.) / M.J. WaringThe Science of Cancer Treatment109,99 €
- Drug Resistance in Cancer Cells110,99 €
- New Frontiers in Anti-Cancer Drug Discovery161,99 €
-
-
-
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 397
- Erscheinungstermin: 1. August 1997
- Englisch
- Abmessung: 260mm x 176mm x 24mm
- Gewicht: 912g
- ISBN-13: 9780824792954
- ISBN-10: 0824792955
- Artikelnr.: 20994594
- Verlag: CRC Press
- Seitenzahl: 397
- Erscheinungstermin: 1. August 1997
- Englisch
- Abmessung: 260mm x 176mm x 24mm
- Gewicht: 912g
- ISBN-13: 9780824792954
- ISBN-10: 0824792955
- Artikelnr.: 20994594
S. Bernal
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher